EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
1,136,824
Share change
-473,044
Total reported value
$11,392,000
Price per share
$10.02
Number of holders
11
Value change
-$4,731,497
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q3 2022

As of 30 Sep 2022, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,136,824 shares. The largest 10 holders included Verition Fund Management LLC, Sio Capital Management, LLC, Wealthspring Capital LLC, Cowen Investment Management LLC, HGC Investment Management Inc., Schechter Investment Advisors, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, GLAZER CAPITAL, LLC, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.